Alternative rapamycin treatment regimens mitigate the impact of rapamycin on glucose homeostasis and the immune system

Arriola Apelo, Sebastian I., Neuman, Joshua C., Baar, Emma L., Syed, Faizan A., Cummings, Nicole E., Brar, Harpreet K., Pumper, Cassidy P., Kimple, Michelle E., Lamming, Dudley W.·2016·Aging Cell

Cited by (181)

Items 101–181 of 181

  1. Dynamic modeling of signal transduction by mTOR complexes in cancer
    Mohammadreza Dorvash, Mohammad Farahmandnia, Pouria Mosaddeghi, Mitra Farahmandnejad, Hosein Saber, Mohammadhossein Khorraminejad‐Shirazi, Amir Azadi, Iman Tavassoly · 2019 · Journal of Theoretical Biology
  2. Rapamycin rescues BMP mediated midline craniosynostosis phenotype through reduction of mTOR signaling in a mouse model
    Kaitrin Kramer, Jingwen Yang, W. Benton Swanson, Satoru Hayano, Masako Toda, Haichun Pan, Jin Koo Kim, Paul H. Krebsbach, Yuji M. Mishina · 2018 · genesis
  3. Rejuvenating aged stem cells: therapeutic strategies to extend health and lifespan
    Francesca Matteini, Sara Montserrat‐Vazquez, Maria Carolina Florian · 2024 · FEBS Letters
  4. Skeletal muscle mitochondrial respiration in a model of age-related osteoarthritis is impaired after dietary rapamycin
    Christian J. Elliehausen, Dennis M. Minton, Alexander D. Nichol, Adam R. Konopka · 2021 · Experimental Gerontology
  5. Intermittent mTOR Inhibition Reverses Kidney Aging in Old Rats
    Andrea Di Francesco, Alberto Díaz‐Ruiz, Rafael de Cabo, Michel Bernier · 2018 · The Journals of Gerontology Series A
  6. Safety Profile of Rapamycin Perfluorocarbon Nanoparticles for Preventing Cisplatin-Induced Kidney Injury
    Qingyu Stephanie Zhou, Justin Doherty, Antonina M. Akk, Luke E. Springer, Ping Fan, Ivan Spasojević, Ganesh V. Halade, Huanghe Yang, Christine T. N. Pham, Samuel A. Wickline et al. · 2022 · Nanomaterials
  7. Rapamycin impairs bone accrual in young adult mice independent of Nrf2
    Stephen A. Martin, Ruben Riordan, Rong Wang, Zhentao Yu, Allan M. Aguirre-Burk, Carmen P. Wong, Dawn A. Olson, Adam J. Branscum, Russell T. Turner, Urszula T. Iwaniec et al. · 2021 · Experimental Gerontology
  8. Rapamycin increases the incidence of neuropsychiatric illness in kidney transplant patients through the suppression of neural stem cells
    Yangsik Kim, Jung Sun Lee, Yeon Ho Joo · 2020 · Translational Psychiatry
  9. Multi-Omic, Histopathologic, and Clinicopathologic Effects of Once-Weekly Oral Rapamycin in a Naturally Occurring Feline Model of Hypertrophic Cardiomyopathy: A Pilot Study
    Victor N. Rivas, Joanna L. Kaplan, Susan A. Kennedy, Stuart Fitzgerald, Amanda E. Crofton, Aisling Farrell, Louise Grubb, Carina E. Jauregui, Gabriela Grigorean, Eunju April Choi et al. · 2023 · Animals
  10. Gut aging: A wane from the normal to repercussion and gerotherapeutic strategies
    Joseph Kofi Abankwah, Ying Wang, Jida Wang, Ogbe Susan Enechojo, Lisa Dal Pozzo, XiaoQian Chu, Yuhong Bian · 2024 · Heliyon
  11. Pharmacologic inhibition of mTORC1 mimics dietary protein restriction in a mouse model of lactation
    Virginia L. Pszczolkowski, Steven J. Halderson, Emma J. Meyer, Amy Lin, Sebastian I. Arriola Apelo · 2020 · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology
  12. The effects of macronutrients metabolism on cellular and organismal aging
    Jamil Nehme, Abdullah Altulea, Teodora Gheorghe, Marco Demaria · 2023 · Biomedical Journal
  13. mTOR inhibitors for treatment of low-risk prostate cancer
    Michael Andre Liss, Lanette Rickborn, John DiGiovanni, Dean J. Bacich, Linda A. deGraffenried, Manish Parihar, Ian Murchie Thompson, Zelton Dave Sharp · 2018 · Medical Hypotheses
  14. The mTORC1 inhibitor rapamycin and the mTORC1/2 inhibitor AZD2014 impair the consolidation and persistence of contextual fear memory
    Phillip E. MacCallum, Jacqueline J. Blundell · 2020 · Psychopharmacology
  15. Nutrition and energetics in rodent longevity research
    Victoria K. Gibbs, Daniel L. Smith · 2016 · Experimental Gerontology
  16. Effects of combined treatment with blood flow restriction and low-current electrical stimulation on muscle hypertrophy in rats
    Madoka Yoshikawa, Takeshi Morifuji, Tomohiro Matsumoto, Noriaki Maeshige, Minoru Tanaka, Hidemi Fujino · 2019 · Journal of Applied Physiology
  17. Superior cancer preventive efficacy of low versus high dose of mTOR inhibitor in a mouse model of prostate cancer
    Marina P. Antoch, Michelle M. Wrobel, Bryan M. Gillard, Karen K. Kuropatwinski, Ilia A. Toshkov, Anatoli S. Gleiberman, Ellen Karasik, Michael T. Moser, Barbara A. Foster, Ekaterina L. Andrianova et al. · 2020 · Oncotarget
  18. Common targets for a deadly duo of diabetes mellitus and colon cancer: Catching two fish with one worm
    Saumitra Gajjar, Bhoomika M. Patel · 2020 · European Journal of Pharmacology
  19. Clinical impact and economic burden of post-transplant infections following heart transplantation: A retrospective nationwide cohort study
    Suk‐Chan Jang, Byeong-Chan Oh, Jin Hyun Nam, Eui‐Kyung Lee, Hye‐Lin Kim, Sun‐Hong Kwon · 2022 · The Journal of Heart and Lung Transplantation
  20. Effects of low-dose rapamycin on lymphoid organs of mice prone and resistant to accelerated senescence
    Rafael dos Santos Barros, Luiz A. D. Queiroz, Josiane Betim de Assis, Kamilla Costa Pantoja, Sofia Xavier Bustia, Emanuella Sarmento Alho de Sousa, Stephen Fernandes Rodrigues, Eliana Hiromi Akamine, Anderson Sá‐Nunes, Joilson Oliveira Martins · 2024 · Frontiers in Immunology
  21. Restored autophagy is protective against PAK3-induced cardiac dysfunction
    Andrea Ruiz‐Velasco, Rida Raja, Xinyi Chen, Haresh Ganenthiran, Namrita Kaur, Nasser hawimel o Alatawi, Jessica M. Miller, Riham Abouleisa, Qinghui Ou, Xiangjun Zhao et al. · 2023 · iScience
  22. Hungering for Immortality.
    Joel C. Eissenberg · 2018 · Europe PMC (PubMed Central)
  23. Rapamycin does not alter bone microarchitecture or material properties quality in young-adult and aged female C57BL/6 mice
    Connor Devine, Kenna C Brown, Kat O Paton, Chelsea M. Heveran, Stephen A Martin · 2024 · JBMR Plus
  24. Peripheral tissular analysis of rapamycin’s effect as a neuroprotective agent in vivo
    Alfredo González-Alcocer, Yareth Gopar‐Cuevas, Adolfo Soto‐Domínguez, María de Jesús Loera‐Arias, Odila Saucedo Cárdenas, Roberto Montes‐de‐Oca‐Luna, Humberto Rodríguez‐Rocha, Aracely García‐García · 2022 · Naunyn-Schmiedeberg s Archives of Pharmacology
  25. Are invertebrates relevant models in ageing research? Focus on the effects of rapamycin on TOR
    Cihan Süleyman Erdogan, Benni Winding Hansen, Ole Vang · 2016 · Mechanisms of Ageing and Development
  26. Silk fibroin/dual drugs eluting polydioxanone monofilament braided ureteral stent with antibacterial and anti-stenotic functions
    Lirong Duan, Jing Wang, Zhijun Miao, Dulin Zuo, Weiwei Sun, Lu Li, Fanlei Yang, Chao Deng, Feng Li, Gang Shen et al. · 2025 · International Journal of Biological Macromolecules
  27. Rapamycin Does Not Compromise Exercise‐Induced Muscular Adaptations in Female Mice
    Christian J. Elliehausen, Szczepan S. Olszewski, Carolyn G. Shult, Aditya R. Ailiani, Michaela E. Trautman, Reji Babygirija, Dudley W. Lamming, Troy Alan Hornberger, Dennis M. Minton, Adam R. Konopka · 2025 · Aging Cell
  28. Semisynthesis of 3‐Hydroxyoxindole Rapamycin Analogues Through Site‐ and Stereoselective Trapping of Oxonium Ylides in RhII‐Catalyzed Three‐Component Reactions
    Lin Qiu, Meng Su, Zhongqing Wen, Xiangcheng Zhu, Yanwen Duan, Yong Ping Huang · 2019 · European Journal of Organic Chemistry
  29. Geroprotectors and Skeletal Health: Beyond the Headlines
    Alexandra Rayson, Maya Boudiffa, Maneeha Naveed, Jon Griffin, Enrico Dall’Ara, Ilaria Bellantuono · 2022 · Frontiers in Cell and Developmental Biology
  30. Pyrans and Benzo Derivatives: Applications
    Dainis Kaldre · 2020 · Elsevier eBooks
  31. Effects of Long-term low-dose intermittent rapamycin administration on glucose metabolism and immune system of SAMP8 and SAMR1 mice
    Luiz A. D. Queiroz, Rafael Santos de Barros, Josiane Betim de Assis, Camille Cristine Caldeira Silva, Walter Miguel Turato, Sofia Xavier Bustia, Stephen Fernandes Rodrigues, Anderson Sá‐Nunes, Joilson Oliveira Martins · 2025 · Frontiers in Immunology
  32. Effects of Rapamycin on Insulin Brain Endothelial Cell Binding and Blood–Brain Barrier Transport
    Steven Nguyen, William A. Banks, Elizabeth M. Rhea · 2021 · Medical Sciences
  33. The Role of S6K1 in Aging and Alzheimer’s Disease: Mechanistic Insights and Therapeutic Potential
    Salvatore Oddo, Marika Lanza, Giovanna Casili, Antonella Caccamo · 2025 · International Journal of Molecular Sciences
  34. A novel rapalog shows improved safety vs. efficacy in a human organoid model of polycystic kidney disease
    Ramila E. Gulieva, Parvaneh Ahmadvand, Benjamin Freedman · 2025 · Stem Cell Reports
  35. Innovations in Vascular Repair from Mechanical Intervention to Regenerative Therapies
    Hye-min Park, Chae-lin Kim, Dasom Kong, Seon-Hee Heo, Hyun‐Ji Park · 2025 · Tissue Engineering and Regenerative Medicine
  36. Insulin Resistance, Secretion and Clearance –Taming the Three Effector Encounter of Type 2 Diabetes
    Jacob Bar‐Tana · 2021 · Frontiers in Endocrinology
  37. Chronic rapamycin pretreatment modulates arginase/inducible nitric oxide synthase balance attenuating aging-dependent susceptibility to Trypanosoma cruzi infection and acute myocarditis
    Margarida P. Santos, Elda Gonçalves-Santos, Matheus Augusto Souza, Ivo Santana Caldas, Graziela Domingues de Almeida Lima, Reggiani Vilela Gonçalves, Rômulo Dias Novaes · 2021 · Experimental Gerontology
  38. Neuroprotection of Everolimus Against Focal Cerebral Ischemia-Reperfusion Injury in Rats
    Fatemeh Forouzanfar, Payam Razavi Ebrahimi, Hamid Reza Sadeghnia · 2022 · Journal of Stroke and Cerebrovascular Diseases
  39. Peptidylprolyl Isomerases as In Vivo Carriers for Drugs That Target Various Intracellular Entities
    Andrzej Gałat · 2017 · Biomolecules
  40. Is rapamycin a rapalog?
    David J. Glass, Dudley W. Lamming · 2018 · Nutrition and Healthy Aging
  41. Individual dietary amino acid restrictions induce distinct metabolic and chromatin states
    Spencer A. Haws, Yang Liu, Cara L. Green, Krittisak Chaiyakul, Pragyan Mishra, Reji Babygirija, Eric A. Armstrong, Anusha T. Mehendale, Irene M. Ong, Dudley W. Lamming et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  42. The rationale for testing drug combinations in aging intervention studies
    Sharma, Kavita, Wang, Juan, Jiang, Zhou, Klug, Jenna, Darvas, Martin, M. Imai, Denise, Snider, Timothy, Niedernhofer, Laura, Ladiges, Warren · 2019 · Aging Pathobiology and Therapeutics
  43. Mikhail ‘Misha’ Blagosklonny’s enduring legacy in geroscience: the hyperfunction theory and the therapeutic potential of rapamycin
    David A. Barzilai · 2025 · Aging
  44. The Neuroprotective Effects and Probable Mechanisms of Everolimus in a Rat Model of Intracerebral Hemorrhage
    Shima Shirzad, Farzaneh Vafaee, Fatemeh Forouzanfar · 2023 · Cellular and Molecular Neurobiology
  45. Rapamycin and rapalogs
    Dudley W. Lamming · 2023 · Elsevier eBooks
  46. Commentary: Rapalink-1 Increased Infarct Size in Early Cerebral Ischemia–Reperfusion With Increased Blood–Brain Barrier Disruption
    Daniel J. Beard, Gina Hadley, Brad A. Sutherland, Alastair Mitchell Buchan · 2021 · Frontiers in Physiology
  47. Interactions Among mTORC, AMPK and SIRT A Computational Model for Cell Energy Balance and Metabolism
    Mehrshad Sadria, Anita T. Layton · 2020 · Research Square
  48. mTOR signaling contributes to system-driven rhythmic gene expression in mouse liver
    Aishwarya Sahasrabudhe, Chanté R. Guy, Audrey Jacq, Chieh-Wen Ho, Ben J. Greenwell, Jérôme S. Menet · 2026 · Science Advances
  49. Nutrient regulation of inflammatory signalling in obesity and vascular disease
    Timothy M. Palmer, Ian P. Salt · 2021 · Clinical Science
  50. CD73-expressing endometrial regenerative cell-derived exosomes mitigate acute cardiac allograft rejection through regulating adenosine metabolism in mice
    Chenglu Sun, Dejun Kong, Hong Qin, Shilong Li, Conglin Wang, Shaohua Ren, Yini Xu, Hongda Wang, Hao Wang · 2025 · Stem Cell Research & Therapy
  51. Impact of Rapamycin on Longevity: Updated Insights
    Mehdi Sanati, Amir R. Afshari, Samaneh Aminyavari, Maciej Banach, Amirhossein Sahebkar · 2024 · Archives of Medical Science
  52. Chemical Proteomics Reveals that the Anticancer Drug Everolimus Affects the Ubiquitin–Proteasome System
    Anna A. Lobas, Amir Ata Saei, Hezheng Lyu, Roman A. Zubarev, Mikhail V. Gorshkov · 2024 · ACS Pharmacology & Translational Science
  53. An mTOR inhibitor discovery system using drug-sensitized yeast
    Andrew Breen, Sarah Ann Thomas, David Beckett, Matthew Agsalud, Graham Gingras, J. Andrew Williams, Brian M. Wasko · 2025 · GeroScience
  54. Rapamycin’s Role in Periodontal Health and Therapeutics: A Scoping Review
    Vinayak Joshi, S. B. Gururaj, Vivek Thumbigere‐Math, Manohar Suresh Kugaji, Eswar Kandaswamy · 2025 · JDR Clinical & Translational Research
  55. Effect of Sirolimus/Metformin Co-Treatment on Hyperglycemia and Cellular Respiration in BALB/c Mice
    Alia Saeed Albawardi, Dhanya Saraswathiamma, Charu Sharma, Abdulghani S. Elomami, Abdul‐Kader Souid, Saeeda Saleh Almarzooqi · 2023 · International Journal of Molecular Sciences
  56. Atrial myocyte senescence as a driver of atrial fibrillation: mechanisms and therapeutic implications
    Zhaoyang Wei, Zhixiong Li, Nanhu Quan · 2026 · Frontiers in Cell and Developmental Biology
  57. Fasting-mimicking diets as a strategy to reprogram tumor metabolism: a systematic review
    Irislene Costa Pereira, Jorddam Almondes Martins, Dallyla Jennifer Morais de Sousa, Maria Shelda de Oliveira Neres, RODRIGO SOARES PEREIRA LIMA, Jheniffer da Silva Sousa, Rebeca Lima Monteiro, Felipe Cavalcanti Carneiro da Silva, Juliana Soares Severo, Francisco Leonardo Torres‐Leal · 2026 · European Journal of Nutrition
  58. Bench to bedside: is rapamycin headed for the docTOR?
    Dudley W. Lamming · 2026 · GeroScience
  59. An All-in-One Photothermal Nanocomposite Hydrogel for Controlling Inducible Transgene Expression
    Rodrigo Serrano-Yamba, Clara Escudero-Duch, Cristina Yus, Marı́a Recuero, Daniel López, Laura Saldaña, Manuel Arruebo, Nuria E. Vilaboa · 2026 · ACS Applied Materials & Interfaces
  60. Rapamycin did not prevent the excessive exercise-induced hepatic fat accumulation
    Ana P. Pinto, Alisson Luiz da Rocha, Giovana Rampazzo Teixeira, Rafael L. Rovina, Allice Santos Cruz Veras, Fabiani Gai Frantz, José Rodrigo Pauli, Leandro Pereira de Moura, Dennys E. Cintra, Eduardo Rochete Ropelle et al. · 2022 · Life Sciences
  61. Sirolimus treatment induces dose-dependent involution of the thymus with elevated cellular respiration in BALB/c mice.
    Saeeda Saleh Almarzooqi, Charu Sharma, Dhanya Saraswathiamma, Ahmed R. Alsuwaidi, Noura Hadid, Abdul‐Kader Souid, Alia Saeed Albawardi · 2022 · PubMed Central
  62. Rapamycin does not compromise physical performance or muscle hypertrophy after PoWeR while intermittent rapamycin alleviates glucose disruptions by frequent rapamycin
    Christian J. Elliehausen, Szczepan S. Olszewski, Carolyn G. Shult, Aditya R. Ailiani, Michaela E. Trautman, Reji Babygirija, Dudley W. Lamming, Troy Alan Hornberger, Dennis M. Minton, Adam R. Konopka · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  63. Paradigmenwechsel in der Anti-Aging- Medizin: Hormesis, Target-of-Rapamycin-Komplex und erste Anti-Aging-Pillen
    Alexander Römmler · 2016 · Journal für Kardiologie (Krause & Pachernegg GmbH)
  64. Paradigmenwechsel in der Anti-Aging- Medizin: Hormesis, Target-of-Rapamycin-Komplex und erste Anti-Aging-Pillen
    Alexander Römmler · 2016
  65. Bone Marrow-Derived Stem Cells as a Cytotherapy for Sirolimus-Induced Periodontal Ligament and Alveolar Bone Injury in a Rat Model
    Rasha Mohamed Taha, Heba Elsaied · 2019 · Egyptian Dental Journal /Egyptian Dental Journal
  66. The conductors of the metabolic orchestra
    Tomas Koltai, Stephan J. Reshkin, Fátima Baltazar, Larry Fliegel · 2021 · Elsevier eBooks
  67. Mecanismos moleculares relacionados ao aumento do conteúdo hepático de gordura em resposta ao excesso de exercício físico
    Ana Paula Pinto · 2021 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  68. Faculty Opinions recommendation of mTOR at the nexus of nutrition, growth, ageing and disease.
    Shawn M. Ferguson · 2020 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  69. Disrupted cellular quality control mechanisms in aging
    Cristina Carvalho, Joana F. Pires, Paula Isabel Moreira, Nuno Raimundo · 2022 · Elsevier eBooks
  70. Combination of Volasertib and Rapamycin Inhibits the Regrowth of TSC2-Deficient Tumors
    Matthildi Valianou, Erik Y. Zhang, Daniel L. Johnson, Rhett Meyers, Maciej M. Markiewski, Magdalena Karbowniczek, Lawrence M. Pfeffer, Jane J. Yu, John J. Bissler, Aristotelis Astrinidis · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  71. O efeito do tratamento com rapamicina em órgãos linfoides de camundongos propensos à senescência acelerada
    Rafael dos Santos Barros · 2023 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  72. An mTOR Inhibitor Discovery System Using the Growth of Drug-Sensitized Yeast Strains
    Anna K. Breen, Sarah Ann Thomas, David Beckett, Matthew Agsalud, Graham Gingras, J. Andrew Williams, Brian M. Wasko · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  73. Electrical alternans of the Q-T interval and fatal arrhythmias caused by neonatal cardiac tumor: a case report
    Ge Wang, Jin Ding, Hongmei Wu, Yanhong Chen, Xiaoqi Deng, Hairui Li, Haiying Li · 2025 · Frontiers in Cardiovascular Medicine
  74. Additional file 3 of Interactions among mTORC, AMPK and SIRT: a computational model for cell energy balance and metabolism
    Mehrshad Sadria, Layton, Anita T. · 2021 · Figshare
  75. Abstract 052 | What is the impact of late-life rapamycin on exercise adaptations in older mice?
    Adam R. Konopka · 2026 · European Journal of Translational Myology
  76. Revisiting old drugs and drug combinations for polycythemia vera and related neoplasms
    Gökhan Mergen, Hans Carl Hasselbalch · 2026 · Frontiers in Hematology
  77. Phase II Trial of Encapsulated Rapamycin to Reduce Polyp Burden Associated with Familial Adenomatous Polyposis
    Joseph C Broderick, Niloy Jewel Samadder, Elena M. Stoffel, John C. Fang, Peter P. Stanich, Paul E. Wise, Randy P. Wright, Guy Travis Clifton, George Earl Peoples, Carol Ann Burke · 2026 · Clinical Cancer Research
  78. From lifespan extension to hallmark-informed gerotherapeutic prioritization: A bibliometric-guided, strategy-oriented review of anti-aging drug research
    Zhen Liu, Ainikaer Abulaiti, Deyu Li, Jiashun Li, Paerhati Wahafu, Yu Zhang, Maerdan Maimaitiming, S Y Li, Guohua Li, Maihemuti Yakufu · 2026 · Ageing Research Reviews
  79. Mathematical and Computational Models of Biochemical Reactions and Cell Signaling—From Ordinary Differential Equations to Machine Learning
    Grzegorz Matyszczak · 2026 · International Journal of Molecular Sciences
  80. Molecular mechanisms of cellular senescence and targeted intervention with natural bioactive compounds
    Silu Zhang, Shijing Ma, Hailong Li, Yuchen Pang, Yangyan Dai, Xiaomeng Liu, Tiantian Zhao, Bin Liu, Huixiong Chen · 2026 · Journal of Dermatologic Science and Cosmetic Technology
  81. The polycentric aging framework: epigenetic regulation as a dominant lifespan-limiting center in human aging
    Michał Bartoszewicz, Mariusz Niemczyk · 2026 · Aging